This federal contract award was issued by the Veterans Integrated Service Network 9, a civilian agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $25,439.82 firm fixed-price delivery order contract does not have a set-aside designation and is set to expire on September 30, 2026.
Immucor holds several significant Indefinite Delivery/Indefinite Quantity (IDIQ) and Blanket Purchase Agreement (BPA) contracts across federal agencies, including a $1,020,000 BPA with the Defense Health Agency through March 2027, a $1,282,859.40 BPA with Veterans Integrated Service Network 4 through September 2026, and a $441,379.40 BPA with Veterans Integrated Service Network 2 through September 2025. These contracts facilitate recurring purchases of blood testing products, reagents, and diagnostic equipment, primarily under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests.
Generated 10/2/25, 10:57 AM